Type |
Details |
Score |
Strain |
Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(TPO-cre)1Shk/? |
Background: |
involves: FVB/N |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Toyoshima M |
Year: |
2009 |
Journal: |
J Comp Neurol |
Title: |
Preferential localization of neural cell recognition molecule NB-2 in developing glutamatergic neurons in the rat auditory brainstem. |
Volume: |
513 |
Issue: |
4 |
Pages: |
349-62 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Contactin-5 (Cntn5) or neural recognition molecule NB-2 mediates cell surface interactions necessary for connectivity during nervous system development and synaptic maintenance during adulthood [, ]. Cntn5 contributes to the development of glutamatergic neurons in the rat auditory brainstem [, ].Contactins are cell adhesion molecules that belong to the immunoglobulin superfamily and are involved in neural development []. They usually consist of six N-terminal Ig domains, four fibronectin type III domains, and a C-terminal glycophosphatidylinositol (GPI)-anchor to the extracellular part of the cell membrane []. |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nkx2-1/Nkx2-1 Tg(TPO-cre)1Shk/? |
Background: |
involves: 129X1/SvJ * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gnas/Gnas Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S6/SvEvTac * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf2/Nf2 Tg(TPO-cre)1Shk/? |
Background: |
involves: 129P2/OlaHsd * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Hoshi S |
Year: |
2009 |
Journal: |
Carcinogenesis |
Title: |
Role of NKX2-1 in N-bis(2-hydroxypropyl)-nitrosamine-induced thyroid adenoma in mice. |
Volume: |
30 |
Issue: |
9 |
Pages: |
1614-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yeager N |
Year: |
2007 |
Journal: |
Cancer Res |
Title: |
Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. |
Volume: |
67 |
Issue: |
3 |
Pages: |
959-66 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Antico-Arciuch VG |
Year: |
2010 |
Journal: |
Oncogene |
Title: |
Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females. |
Volume: |
29 |
Issue: |
42 |
Pages: |
5678-86 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Antico Arciuch VG |
Year: |
2011 |
Journal: |
Oncotarget |
Title: |
Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors. |
Volume: |
2 |
Issue: |
12 |
Pages: |
1109-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Knauf JA |
Year: |
2011 |
Journal: |
Oncogene |
Title: |
Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling. |
Volume: |
30 |
Issue: |
28 |
Pages: |
3153-62 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Publication |
First Author: |
Antico Arciuch VG |
Year: |
2013 |
Journal: |
Cancer Res |
Title: |
Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cells. |
Volume: |
73 |
Issue: |
17 |
Pages: |
5459-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jezek J |
Year: |
2019 |
Journal: |
J Cell Sci |
Title: |
Synergistic repression of thyroid hyperplasia by cyclin C and Pten. |
Volume: |
132 |
Issue: |
16 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Yeager N |
Year: |
2008 |
Journal: |
Cancer Res |
Title: |
Mammalian target of rapamycin is the key effector of phosphatidylinositol-3-OH-initiated proliferative signals in the thyroid follicular epithelium. |
Volume: |
68 |
Issue: |
2 |
Pages: |
444-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pringle DR |
Year: |
2012 |
Journal: |
Endocr Relat Cancer |
Title: |
Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer. |
Volume: |
19 |
Issue: |
3 |
Pages: |
435-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kurashige T |
Year: |
2019 |
Journal: |
Endocrinology |
Title: |
Basal Autophagy Deficiency Causes Thyroid Follicular Epithelial Cell Death in Mice. |
Volume: |
160 |
Issue: |
9 |
Pages: |
2085-2092 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin CI |
Year: |
2011 |
Journal: |
Surgery |
Title: |
Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity. |
Volume: |
150 |
Issue: |
6 |
Pages: |
1295-302 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pten/Pten Tg(TPO-cre)1Shk/? |
Background: |
129S1.Cg-Pten Tg(TPO-cre)1Shk |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn1b/Cdkn1b Pten/Pten Tg(TPO-cre)1Shk/? |
Background: |
129S1.Cg-Cdkn1b Tg(TPO-cre)1Shk Pten |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdkn1b/Cdkn1b<+> Pten/Pten Tg(TPO-cre)1Shk/? |
Background: |
129S1.Cg-Cdkn1b Tg(TPO-cre)1Shk Pten |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/? Tg(TPO-cre)1Shk/? |
Background: |
involves: FVB/NCr * FVB/NJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pten/Pten Trp53/Trp53 Tg(TPO-cre)1Shk/? |
Background: |
129.Cg-Tg(TPO-cre)1Shk Trp53 Pten |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kras/Kras<+> Tg(TPO-cre)1Shk/? |
Background: |
129.Cg-Kras Tg(Tpo-cre)1Shk |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Prkar1a/Prkar1a Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pten/Pten Tg(TPO-cre)1Shk/? |
Background: |
involves: 129 * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kras/Kras Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6N * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tbx3/Tbx3 Tg(TPO-cre)1Shk/? |
Background: |
involves: FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Miller KA |
Year: |
2009 |
Journal: |
Cancer Res |
Title: |
Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo. |
Volume: |
69 |
Issue: |
8 |
Pages: |
3689-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kusakabe T |
Year: |
2006 |
Journal: |
Mol Endocrinol |
Title: |
Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid. |
Volume: |
20 |
Issue: |
8 |
Pages: |
1796-809 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kusakabe T |
Year: |
2004 |
Journal: |
Genesis |
Title: |
Thyrocyte-specific expression of Cre recombinase in transgenic mice. |
Volume: |
39 |
Issue: |
3 |
Pages: |
212-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Knauf JA |
Year: |
2018 |
Journal: |
J Clin Invest |
Title: |
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers. |
Volume: |
128 |
Issue: |
9 |
Pages: |
4086-4097 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shimamura M |
Year: |
2018 |
Journal: |
PLoS One |
Title: |
Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels. |
Volume: |
13 |
Issue: |
8 |
Pages: |
e0201365 |
|
•
•
•
•
•
|
Publication |
First Author: |
Diallo-Krou E |
Year: |
2009 |
Journal: |
Endocrinology |
Title: |
Paired box gene 8-peroxisome proliferator-activated receptor-gamma fusion protein and loss of phosphatase and tensin homolog synergistically cause thyroid hyperplasia in transgenic mice. |
Volume: |
150 |
Issue: |
11 |
Pages: |
5181-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ock S |
Year: |
2011 |
Journal: |
Endocr J |
Title: |
Conditional deletion of insulin receptor in thyrocytes does not affect thyroid structure and function. |
Volume: |
58 |
Issue: |
11 |
Pages: |
1013-9 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Sponziello M |
Year: |
2013 |
Journal: |
Endocrinology |
Title: |
Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. |
Volume: |
154 |
Issue: |
9 |
Pages: |
3043-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pringle DR |
Year: |
2014 |
Journal: |
J Clin Endocrinol Metab |
Title: |
Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice. |
Volume: |
99 |
Issue: |
5 |
Pages: |
E804-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kari S |
Year: |
2019 |
Journal: |
Front Endocrinol (Lausanne) |
Title: |
PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer. |
Volume: |
10 |
|
Pages: |
769 |
|
•
•
•
•
•
|
Publication |
First Author: |
Russart KLG |
Year: |
2018 |
Journal: |
Horm Behav |
Title: |
Elevated aggressive behavior in male mice with thyroid-specific Prkar1a and global Epac1 gene deletion. |
Volume: |
98 |
|
Pages: |
121-129 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pten/Pten Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S4/SvJae * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hras/? Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S6/SvEvTac * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Braf/? Tg(TPO-cre)1Shk/? |
Background: |
involves: 129P2/OlaHsd * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hras/Hras Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S6/SvEvTac * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kras/Kras<+> Pten/Pten Tg(TPO-cre)1Shk/? |
Background: |
129.Cg-Kras Tg(Tpo-cre)1Shk Pten |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Prkar1a/Prkar1a Pten/Pten Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Prkar1a/Prkar1a<+> Pten/Pten<+> Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S4/SvJaeSor * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Ashtekar A |
Year: |
2018 |
Journal: |
J Clin Endocrinol Metab |
Title: |
Alterations in Sod2-Induced Oxidative Stress Affect Endocrine Cancer Progression. |
Volume: |
103 |
Issue: |
11 |
Pages: |
4135-4145 |
|
•
•
•
•
•
|
Publication |
First Author: |
Charles RP |
Year: |
2011 |
Journal: |
Cancer Res |
Title: |
Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse. |
Volume: |
71 |
Issue: |
11 |
Pages: |
3863-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zou M |
Year: |
2016 |
Journal: |
Oncogene |
Title: |
TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer. |
Volume: |
35 |
Issue: |
15 |
Pages: |
1909-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Garcia-Rendueles ME |
Year: |
2015 |
Journal: |
Cancer Discov |
Title: |
NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. |
Volume: |
5 |
Issue: |
11 |
Pages: |
1178-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Untch BR |
Year: |
2018 |
Journal: |
Cancer Res |
Title: |
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers. |
Volume: |
78 |
Issue: |
16 |
Pages: |
4642-4657 |
|
•
•
•
•
•
|
Publication |
First Author: |
Orlacchio A |
Year: |
2017 |
Journal: |
Cancer Res |
Title: |
SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance. |
Volume: |
77 |
Issue: |
24 |
Pages: |
6914-6926 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhu X |
Year: |
2014 |
Journal: |
Neoplasia |
Title: |
Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation. |
Volume: |
16 |
Issue: |
9 |
Pages: |
757-69 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dobson ME |
Year: |
2011 |
Journal: |
Endocrinology |
Title: |
Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma. |
Volume: |
152 |
Issue: |
11 |
Pages: |
4455-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu J |
Year: |
2018 |
Journal: |
Endocrinology |
Title: |
Thyroid-Specific PPARγ Deletion Is Benign in the Mouse. |
Volume: |
159 |
Issue: |
3 |
Pages: |
1463-1468 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang X |
Year: |
2020 |
Journal: |
Oxid Med Cell Longev |
Title: |
Thyroid Stimulating Hormone Triggers Hepatic Mitochondrial Stress through Cyclophilin D Acetylation. |
Volume: |
2020 |
|
Pages: |
1249630 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen X |
Year: |
2009 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Endogenous expression of Hras(G12V) induces developmental defects and neoplasms with copy number imbalances of the oncogene. |
Volume: |
106 |
Issue: |
19 |
Pages: |
7979-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zou M |
Year: |
2017 |
Journal: |
Cancer Res |
Title: |
Cyp24a1 Attenuation Limits Progression of BrafV600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720. |
Volume: |
77 |
Issue: |
8 |
Pages: |
2161-2172 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zou M |
Year: |
2015 |
Journal: |
Lab Invest |
Title: |
KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1. |
Volume: |
95 |
Issue: |
11 |
Pages: |
1269-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jolly LA |
Year: |
2016 |
Journal: |
Cancer Res |
Title: |
Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss. |
Volume: |
76 |
Issue: |
7 |
Pages: |
1804-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huk DJ |
Year: |
2018 |
Journal: |
Thyroid |
Title: |
Deletion of Rap1b, but not Rap1a or Epac1, Reduces Protein Kinase A-Mediated Thyroid Cancer. |
Volume: |
28 |
Issue: |
9 |
Pages: |
1153-1161 |
|
•
•
•
•
•
|
Publication |
First Author: |
Montero-Conde C |
Year: |
2013 |
Journal: |
Cancer Discov |
Title: |
Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas. |
Volume: |
3 |
Issue: |
5 |
Pages: |
520-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ma R |
Year: |
2014 |
Journal: |
Front Endocrinol (Lausanne) |
Title: |
Stemness is Derived from Thyroid Cancer Cells. |
Volume: |
5 |
|
Pages: |
114 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nagarajah J |
Year: |
2016 |
Journal: |
J Clin Invest |
Title: |
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine. |
Volume: |
126 |
Issue: |
11 |
Pages: |
4119-4124 |
|
•
•
•
•
•
|
Publication |
First Author: |
Parhar RS |
Year: |
2016 |
Journal: |
Lab Invest |
Title: |
IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse model. |
Volume: |
96 |
Issue: |
1 |
Pages: |
89-97 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Pten/Pten Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/? Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S4/SvJae * FVB/NCr * FVB/NJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Braf/Braf Tg(TPO-cre)1Shk/? |
Background: |
involves: 129P2/OlaHsd * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Braf/Braf Tshr/Tshr Tg(TPO-cre)1Shk/? |
Background: |
involves: 129P2/OlaHsd * 129S1/Sv * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Braf/Braf Gnas/Gnas Tg(TPO-cre)1Shk/? |
Background: |
involves: 129P2/OlaHsd * 129S6/SvEvTac * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hras/Hras Nf2/Nf2 Tg(TPO-cre)1Shk/? |
Background: |
involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hras/Hras Trp53/Trp53 Tg(TPO-cre)1Shk/? |
Background: |
involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hras/Hras Pten/Pten Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S1/Sv * 129S6/SvEvTac * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kras/Kras Thrb/Thrb Tg(TPO-cre)1Shk/? |
Background: |
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6N * FVB/NCr |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Zuko A |
Year: |
2011 |
Journal: |
Adv Protein Chem Struct Biol |
Title: |
Contactins: structural aspects in relation to developmental functions in brain disease. |
Volume: |
84 |
|
Pages: |
143-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang X |
Year: |
2023 |
Journal: |
JCI Insight |
Title: |
Perturbation of endoplasmic reticulum proteostasis triggers tissue injury in the thyroid gland. |
Volume: |
8 |
Issue: |
12 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Franco AT |
Year: |
2011 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. |
Volume: |
108 |
Issue: |
4 |
Pages: |
1615-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Montero-Conde C |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene. |
Volume: |
114 |
Issue: |
25 |
Pages: |
E4951-E4960 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Z |
Year: |
2024 |
Journal: |
Nat Commun |
Title: |
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis. |
Volume: |
15 |
Issue: |
1 |
Pages: |
4108 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mohebiany AN |
Year: |
2014 |
Journal: |
Adv Neurobiol |
Title: |
New insights into the roles of the contactin cell adhesion molecules in neural development. |
Volume: |
8 |
|
Pages: |
165-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saqcena M |
Year: |
2021 |
Journal: |
Cancer Discov |
Title: |
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies. |
Volume: |
11 |
Issue: |
5 |
Pages: |
1158-1175 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kirschner LS |
Year: |
2016 |
Journal: |
Mol Cell Endocrinol |
Title: |
Mouse models of thyroid cancer: A 2015 update. |
Volume: |
421 |
|
Pages: |
18-27 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1098
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
893
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
893
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
893
 |
Fragment?: |
false |
|
•
•
•
•
•
|